During the past decade, Tagesklinik Landshut; Hämatologie/Onkologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tagesklinik Landshut; Hämatologie/Onkologie" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Tagesklinik Landshut; Hämatologie/Onkologie" are "B-cell Lymphoma" (1 trials), "Gastric Cancer" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Tagesklinik Landshut; Hämatologie/Onkologie" in a lesser frequency.

Most popular intervention types in "Tagesklinik Landshut; Hämatologie/Onkologie" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Obinutuzumab" (2 trials), "Rituximab" (2 trials), "Bendamustine" (1 trials), "Bevacizumab" (1 trials) and "CHOP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tagesklinik Landshut; Hämatologie/Onkologie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Tagesklinik Landshut; Hämatologie/Onkologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Tagesklinik Landshut; Hämatologie/Onkologie, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tagesklinik Landshut; Hämatologie/Onkologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".